Bill Berkrot

(Reuters) - The explosive growth in the sales of Regeneron Pharmaceuticals Inc's Eylea eye drug slowed in the second quarter as existing patients moved to less-frequent dosing. Shares of Regeneron...

(Reuters) - The explosive growth in the sales of Regeneron Pharmaceuticals Inc's Eylea eye drug slowed in the second quarter as existing patients moved to less-frequent dosing. Shares of Regeneron...

NEW YORK (Reuters) - Vivus Inc's largest shareholder on Tuesday took the unusual step of naming the man it would install as the drugmaker's chief executive should it prevail in...

NEW YORK (Reuters) - Vivus Inc's largest shareholder on Tuesday took the unusual step of naming the man it would install as the drugmaker's chief executive should it prevail in...

(Reuters) The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism...

(Reuters) The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism...

WASHINGTON/NEW YORK (Reuters) - The Supreme Court ruled on Monday that generic drugmakers cannot be sued under state law for adverse reactions to their products, a decision that consumer advocates...

WASHINGTON/NEW YORK (Reuters) - The Supreme Court ruled on Monday that generic drugmakers cannot be sued under state law for adverse reactions to their products, a decision that consumer advocates...

(Reuters) - Roche Holding AG's drug Avastin helped prolong the lives of women with advanced cervical cancer when added to chemotherapy in a late-stage clinical trial, likely paving the way...